Short-Term Debt to Equity Ratio: Neumora Therapeutics (NMRA)
Neumora Therapeutics leverages computational biology to develop neuropsychiatric drugs, making its success dependent on the outcomes of future trials. The lack of in-house manufacturing facilities forces the company to utilize external CRO services. The asset's price trajectory on GURU.Markets, where the indicator stands at 0.05, complements the picture of partnerships with biopharma behemoths to develop personalized depression therapies based on big data analysis.
neumoratx.com (NMRA) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Analysis of all company metrics:Neumora Therapeutics Inc NMRA
For Neumora Therapeutics (NMRA), which invests in AI platforms for CNS disorder drug discovery, the liability balance is critical. This ratio compares the volume of short-term loans to total equity, measuring the company's dependence on rapid refinancing. By analyzing the current short-term debt-to-equity ratio, an investor assesses liquidity risk during the deployment of costly digital systems. The stability of this indicator confirms financial resilience when scaling biomarker research.
Analysis of competing companies
Short-Term Debt to Capital BIIB|NBIX - Current Liabilities to Capital|Regencell Bioscience - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital axsome.com AXSM|ACAD - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Short-Term Debt to Equity|Current Liabilities to Capital Supernus Corp (SUPN)|Short-Term Debt to Equity Catalyst Pharmaceuticals|Short-Term Debt to Capital Ratio DNLI (denalitherapeutics.com)|Short-Term Debt to Capital HRMY|BHVN - Current Liabilities to Capital|Amylyx - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Trevi Corp TRVI|PRAX - Short-Term Debt to Equity|anavex.com (AVXL) - Short-Term Debt to Equity Ratio|CeriBell (CBLL) - Short-Term Debt to Equity|Current Liabilities to Capital Prothena Biosciences (PRTA)|Short-Term Debt to Equity Alector Inc.|ANNX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital OMER|Short-Term Debt to Capital neurogene.com (NGNE)|AC Immune SA - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital VYGR|SCLX: Short-Term Debt to Equity Ratio|Tevogen Bio Inc. - Short-Term Loans to Capital Ratio|ACOG: Short-Term Debt to Capital|cogrx.com - Ratio of Short-Term Indebtedness to Capital|IKT (Inhibikase Therapeutics, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Cassava Sciences Inc SAVA|Short-Term Debt to Equity Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VTGN (Vistagen)|Short-Term Debt to Capital Ovid Therapeutics Inc OVID|ABOS - Short-Term Debt to Equity|Current Liabilities to Equity CRVO|ATHE: Short-Term Debt to Capital|Current Liabilities to Capital Clene (CLNN)|Short-Term Debt to Equity Ratio PEPG|Short-Term Debt to Capital jupiterneurosciences.com|Short-Term Debt to Equity Ratio RLMD (Relmada Therapeutics, Inc.)|Short-Term Loans to Capital Ratio ANVS|Short-Term Debt to Capital GRCE (Grace Therapeutics)|Short-Term Debt to Capital Coefficient Firefly Neuro (AIFF)|ANEW Medical, Inc. - Short-Term Debt to Capital|NeuroSense Therapeutics (NRSN) - Short-Term Debt to Equity Ratio|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Short-Term Debt to Equity|MTVA - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity NeurAxis, Inc|Short-Term Debt to Capital Ratio HSDT (Helius Medical Technologies Inc.)|Short-Term Debt to Equity Passage Bio, Inc. (PASG)|Short-Term Debt to Equity Ratio bionomics.com.au NEUP|Short-Term Debt to Equity Minerva Neurosciences, Inc. NERV|Ratio of Short-Term Indebtedness to Capital ATHA|Addex Therapeutics, Ltd. - Short-Term Debt to Capital|ALZN - Short-Term Debt to Capital|cyclerion.com (CYCN) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio PTIX|KTTA (Pasithea Therapeutics Corp) - Short-Term Debt to Capital|Current Liabilities to Capital Cortigent Medical CRGT|Short-Term Debt to Equity Ratio ATXI (Avenue Therapeutics, Inc)|Short-Term Debt to Capital BrainStorm Cell Therapeutics Inc. (BCLI)|Short-Term Debt to Equity Cara Therapeutics, Inc. CARA|Ratio of Short-Term Indebtedness to Capital CHRO|ELYM - Short-Term Debt to Equity|Current Liabilities to Capital Intra-Cellular Therapies|Longboard Pharma (LBPH) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio MRNS|NKGN (NKGen Biotech, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital neurobopharma.com NRBO|Short-Term Debt to Equity Ratio SAGE (Sage Therapeutics)|Short-Term Debt to Capital Synaptogenix Inc. (SNPX)|Short-Term Debt to Equity Trevena, Inc TRVN|VIGL - Short-Term Debt to Equity Ratio|WENA - Short-Term Debt to Equity|Current Liabilities to Capital cerevel.com